For research use only. Not for therapeutic Use.
A-61603 is a selective α1A-adrenergic receptor agonist[1]. A-61603 increases the frequency of spontaneous Ca2+ transients in rat ventricular myocytes in vitro[2].
| Catalog Number | R026118 |
| CAS Number | 107756-30-9 |
| Synonyms | N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide;hydrobromide |
| Molecular Formula | C14H20BrN3O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C14H19N3O3S.BrH/c1-21(19,20)17-13-10-3-2-4-11(14-15-7-8-16-14)9(10)5-6-12(13)18;/h5-6,11,17-18H,2-4,7-8H2,1H3,(H,15,16);1H |
| InChIKey | LRFLWCZMTGTUEP-UHFFFAOYSA-N |
| SMILES | CS(=O)(=O)NC1=C(C=CC2=C1CCCC2C3=NCCN3)O.Br |
| Reference | [1]. Meyer MD, et al. Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: A novel selective α1A receptor agonist. J. Med. Chem. 39(20), 4116-4119 (1 |
